home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gene Therapy Rescues Immunodeficiency

  April, 12 2006 9:21
your information resource in human molecular genetics
A paper in the April issue of Nature Medicine reports clinical improvement on two adults who received gene therapy for the treatment of X-linked chronic granulomatous disease (X-CGD).

X-CGD is an immunodeficiency caused by a defect in the oxidative antimicrobial activity of phagocytes -- a subpopulation of cells in the immune system. The disorder results from mutations in the gene gp91phox. The authors found substantial transfer of the gp91phox gene in both individuals, leading to a large number of functionally corrected phagocytes and notable clinical improvement.

Although the sites of the genome in which the gp91phox gene was inserted probably reinforced the therapeutic efficacy in this trial, these results suggest that gene therapy can be useful to treat X-CGD.

Author contact

Manuel Grez (Georg-Speyer-Haus, Gene Therapy Unit, Frankfurt, Germany)
E-mail: grez@em.uni-frankfurt.de

(C) Nature Medicine press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2021 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.